QA: Savara Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001160308_2022_Savara_Inc.pdf

Logs

Graph

Absolute values for 0001160308, Savara Inc

  xvar xval
0 AssetsCurrent 165,000,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 73,000
3 remainder_Assets 11,525,000
4 LiabilitiesCurrent 14,660,000
5 LiabilitiesNoncurrent 17,440,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,364,479
9 ResearchAndDevelopmentExpense 29,197,674
10 remainder_Expenses 149,750
11 remainder_Revenues 2,366
12 remainder_NetIncome -1,036,154
13 remainder_ComprehensiveNetIncome -57,433
  yvar yval
0 Assets 176,598,000
1 Liabilities 32,100,000
2 Expenses 41,711,903
3 Revenues 2,366
4 StockholdersEquity 144,498,000
5 NetIncome -42,745,691
6 ComprehensiveNetIncome -42,774,408
7 BaseVar 125,752,928
8 EconomicCapitalRatiobeforeLimitedLiability 2.61
9 EconomicCapitalRatio 3.43

Edgar->Model Mapping

Feature Distribution

Change over Time